Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2018-09-13
Sale
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
107,814$4.94$532,601
2018-09-12
Sale
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
189,754$5.06$960,155
2018-02-28
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
See Remarks, Director
64,600$9.95$642,770
2018-02-28
Purchase
Sorrento Therapeutics, Inc.SRNENg George K
See Remarks
90,000$9.95$895,499
2018-02-07
Sale
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
150,000$7.19$1,078,500
2018-02-06
Sale
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
512,912$6.75$3,462,156
2018-02-05
Sale
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
70,721$8.00$565,768
2018-01-30
Sale
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
235,156$7.65$1,798,943
2018-01-29
Sale
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
74,844$7.61$569,562
2018-01-24
Sale
Sorrento Therapeutics, Inc.SRNEAsia Pacific MedTech (BVI) Ltd
10% owner
577,962$7.52$4,346,274
2018-01-23
Sale
Sorrento Therapeutics, Inc.SRNEAsia Pacific MedTech (BVI) Ltd
10% owner
106,326$7.82$831,469
2017-06-15
Purchase
Sorrento Therapeutics, Inc.SRNESHAH JAISIM
Director
10,002$1.79$17,903
2017-06-15
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
29,001$1.81$52,491
2017-04-19
Purchase
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
550,000$2.00$1,100,000
2017-04-19
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
100,000$2.00$200,000
2017-04-13
Purchase
Sorrento Therapeutics, Inc.SRNEABG Management Ltd
10% owner
2,500,000$2.00$5,000,000
2017-02-22
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
2,000$5.60$11,200
2017-02-10
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
20,000$5.15$103,000
2017-02-03
Purchase
Sorrento Therapeutics, Inc.SRNEZELDIS JEROME B
See Remarks
10,000$5.15$51,500
2017-02-03
Purchase
Sorrento Therapeutics, Inc.SRNESHAH JAISIM
Director
10,000$5.15$51,500
2017-02-03
Sale
Sorrento Therapeutics, Inc.SRNENg George K
See Remarks
40,000$5.15$206,000
2017-02-03
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
20,000$5.15$103,000
2017-02-03
Purchase
Sorrento Therapeutics, Inc.SRNEHerde Kevin
Executive VP and CFO
3,000$5.15$15,450
2017-02-03
Purchase
Sorrento Therapeutics, Inc.SRNESu Jeffrey
Executive VP and COO
4,000$5.15$20,600
2017-02-03
Purchase
Sorrento Therapeutics, Inc.SRNEJanda Kim
Director
3,000$5.15$15,450
2017-02-03
Purchase
Sorrento Therapeutics, Inc.SRNEWu Yue Alexander
Director
5,000$5.15$25,750
2016-06-29
Sale
Sorrento Therapeutics, Inc.SRNESOON-SHIONG PATRICK
10% owner
3,400$5.82$19,788
2016-06-23
Sale
Sorrento Therapeutics, Inc.SRNESOON-SHIONG PATRICK
10% owner
6,901$5.85$40,370
2016-06-15
Sale
Sorrento Therapeutics, Inc.SRNESOON-SHIONG PATRICK
10% owner
19,836$5.87$116,437
2016-06-14
Sale
Sorrento Therapeutics, Inc.SRNESOON-SHIONG PATRICK
10% owner
15,972$6.11$97,588
2016-06-13
Sale
Sorrento Therapeutics, Inc.SRNESOON-SHIONG PATRICK
10% owner
37,792$6.15$232,420
2016-03-07
Sale
Sorrento Therapeutics, Inc.SRNESOON-SHIONG PATRICK
10% owner
85,300$6.17$526,301
2016-03-04
Sale
Sorrento Therapeutics, Inc.SRNESOON-SHIONG PATRICK
10% owner
14,700$6.34$93,198
2015-08-26
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
500$0.95$475
2015-08-24
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
8,888$12.84$114,121
2015-08-21
Purchase
Sorrento Therapeutics, Inc.SRNEJi Henry
President and CEO, Director
8,888$13.08$116,255

1 2 Next >

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*